UAB leads a team that crafts new American College of Rheumatology guidelines for 2015 on treatment of rheumatoid arthritis.
Treating patients 50 and older with high blood pressure to a systolic blood pressure of less than 120 mm Hg reduced rates of cardiovascular events, including heart attack, heart failure and stroke, by 25 percent.
Published in Faculty Excellence
A drug derived from female hormones that may help soldiers survive major blood loss on a battlefield will undergo first human testing at UAB.
Telemedicine helps UAB take pulmonary rehabilitation into the home via smartphone technology, in an effort to reduce hospital readmissions from COPD.
The new internal medicine and pediatric clinic will feature an outpatient diagnostic center with a cutting-edge imaging facility and full ambulatory lab services, all on-site.
Summary: Several activities are planned in and around UAB for Breast Cancer Awareness Month.
Published in Service to Community
Lower blood pressure target of 120 mm Hg greatly reduces cardiovascular complications and deaths in older adults.
An Arizona drug company will patent the small peptide drug.
UAB offers two national clinical trials with customized treatment for lung cancer patients.
Published in Focus on Patient Care
Macrophage cells require agility to scavenge and digest dead cells and prevent an immune response to self. In lupus, the macrophages lose that agility.
The protective effect is achieved by reducing acute inflammation in the spleen and the left ventricle of the heart.
UAB discovery gives better understanding of and potential therapies for septic shock and reperfusion injuries.
UAB physician chosen to lead state chapter of the American College of Physicians.
Published in Faculty Excellence
Harvey Makadon, M.D., director of the National LGBT Health Education Center at the Fenway Institute, will be at UAB on March 11.
5K Color Run hosted by Oak Mountain High School students to raise money for cancer research at UAB.
Published in Service to Community
Donation from Dai-ichi Life Insurance Company and Protective Life Corporation will aid new disease-changing therapies in the ADDA pipeline.

Cycliad, a unique biking event, comes to Birmingham for the first time to support navigation services for cancer patients
Published in Service to Community
Renowned UAB HPV expert Warner Huh says new nine-valent HPV vaccine has the potential to eradicate the majority of cervical cancer.
Published in Focus on Patient Care
BCRFA continues to provide substantial gifts to UAB Cancer Center to accelerate breast cancer research.
UAB neurology researcher Kristen Triebel gets substantial American Cancer Society grant to investigate the ability of patients to understand, choose and consent to treatment.
Published in Focus on Patient Care
Page 1 of 6
Back to Top